| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |